astrazeneca summit - Search News

News

AstraZeneca, Summit Therapeutics

Bloomberg on MSN · 1d

Summit Is in Talks for $15 Billion Partnership With AstraZeneca

AstraZeneca Plc is discussing a partnership deal with Summit Therapeutics Inc. in which it could pay as much as $15 billion over time to license a lung-cancer drug, according to people familiar with the matter.

Seeking Alpha · 14h

Summit Therapeutics: AstraZeneca Partnership Could Be A Game-Changer, But Clinical Risks Remain

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and challenges shaping SMMT's future.

The Pharma Letter · 14h

AstraZeneca in talks with Summit for over $15 billion license deal

UK pharma major AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with the matter.

1don MSN

Why AstraZeneca Stock Got Thumped on Thursday

A cautious market traded AstraZeneca stock down by more than 2% following the report, on a day when the S&P 500 index landed ...

1d

AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ...

Summit climbs on rumour of $15bn AstraZeneca interest

Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on ...

1don MSN

Why Summit Therapeutics Stock Soared 8% Higher Today

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

7d

4 questions to ask yourself before betting on AI in your business - and why

AI has the potential to democratize information and enhance productivity - but at Snowflake Summit 2025, business leaders ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results